These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28778437)

  • 1. Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteins.
    Lindsey JW
    J Neuroimmunol; 2017 Sep; 310():131-134. PubMed ID: 28778437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins.
    Dooley MM; de Gannes SL; Fu KA; Lindsey JW
    J Neuroimmunol; 2016 Oct; 299():147-151. PubMed ID: 27725113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L.
    Lindsey JW; deGannes SL; Pate KA; Zhao X
    Mol Immunol; 2016 Jan; 69():7-12. PubMed ID: 26637929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
    Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
    Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teriflunomide's effect on humoral response to Epstein-Barr virus and development of cortical gray matter pathology in multiple sclerosis.
    Zivadinov R; Ramanathan M; Hagemeier J; Bergsland N; Ramasamy DP; Durfee J; Kolb C; Weinstock-Guttman B
    Mult Scler Relat Disord; 2019 Nov; 36():101388. PubMed ID: 31525628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concentrations of antibodies to Epstein-Barr virus decrease during ocrelizumab treatment.
    Pham HPT; Saroukhani S; Lindsey JW
    Mult Scler Relat Disord; 2023 Feb; 70():104497. PubMed ID: 36603289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis.
    Castellazzi M; Tamborino C; Cani A; Negri E; Baldi E; Seraceni S; Tola MR; Granieri E; Contini C; Fainardi E
    Mult Scler; 2010 Jul; 16(7):883-7. PubMed ID: 20483883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
    De Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
    Najafipoor A; Roghanian R; Zarkesh-Esfahani SH; Bouzari M; Etemadifar M
    Cell Immunol; 2015 Mar; 294(1):9-12. PubMed ID: 25666504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis and Epstein-Barr virus.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.
    Mouhieddine TH; Darwish H; Fawaz L; Yamout B; Tamim H; Khoury SJ
    Clin Immunol; 2015 May; 158(1):59-66. PubMed ID: 25805657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis.
    Pfuhl C; Oechtering J; Rasche L; Gieß RM; Behrens JR; Wakonig K; Freitag E; Pache FC; Otto C; Hofmann J; Eberspächer B; Bellmann-Strobl J; Paul F; Ruprecht K
    J Neuroimmunol; 2015 Aug; 285():156-60. PubMed ID: 26198934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.
    Liu Y; Huang Q; Liu W; Liu Q; Jia W; Chang E; Chen F; Liu Z; Guo X; Mo H; Chen J; Rao D; Ye W; Cao S; Hong M
    Int J Cancer; 2012 Jul; 131(2):406-16. PubMed ID: 21866545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
    Kvistad S; Myhr KM; Holmøy T; Bakke S; Beiske AG; Bjerve KS; Hovdal H; Løken-Amsrud KI; Lilleås F; Midgard R; Njølstad G; Pedersen T; Benth JŠ; Wergeland S; Torkildsen O
    Mult Scler; 2014 Dec; 20(14):1833-40. PubMed ID: 24842958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of anti-Epstein-Barr virus antibodies in children and adolescents with secondary immunodeficiency].
    Bucková A
    Epidemiol Mikrobiol Imunol; 2010 Aug; 59(3):133-7. PubMed ID: 20925250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic evaluation of a new panel of assays for Epstein-Barr virus serology.
    Radtke M; Gärtner B; Franke D
    Clin Lab; 2007; 53(3-4):149-50. PubMed ID: 17447650
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibodies to an Epstein Barr Virus protein that cross-react with dsDNA have pathogenic potential.
    Singh D; Oudit O; Hajtovic S; Sarbaugh D; Salis R; Adebowale T; James J; Spatz LA
    Mol Immunol; 2021 Apr; 132():41-52. PubMed ID: 33545624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
    Nejati A; Shoja Z; Shahmahmoodi S; Tafakhori A; Mollaei-Kandelous Y; Rezaei F; Hamid KM; Mirshafiey A; Doosti R; Sahraian MA; Mahmoudi M; Shokri F; Emery V; Marashi SM
    Med Microbiol Immunol; 2016 Apr; 205(2):143-54. PubMed ID: 26365612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.